Glanbia acquires Seltzer
This article was originally published in The Tan Sheet
Consumer foods and ingredients firm Glanbia plc will further develop its international nutritionals business and enter "key global growth markets" through its acquisition of Calif-based Seltzer Companies, according to Glanbia's Group Managing Director John Maloney. Currently, the international firm's major U.S. presence is in the dairy market, according to Glanbia's website. The firm also produces the branded whey protein isolate BarFlex in the U.S. and has several other branded whey and milk-based ingredients. In addition to increasing its global presence, the purchase also "creates the opportunity to extend Glanbia's major investment in innovation and clinical research in nutritional products with science-based health benefits," the firm states in a Sept. 6 release. The $105 mil. transaction awaits FTC approval and Glanbia expects completion of the deal in October. Wayne Seltzer will continue to run the Seltzer business, Glanbia adds...
You may also be interested in...
With its $315 million purchase of sports nutritional supplement firm Optimum Nutrition, Kilkenny, Ireland-based Glanbia continues to internationalize its business, according to an Aug. 25 release. Glanbia Group Managing Director John Moloney says the deal gives Glanbia "a leading position of scale in a fast- growing segment of the nutrition market." Optimum Nutrition brands such as Gold Standard 100% Whey also bring Glanbia "up the value chain into consumer markets," Moloney says. In September 2006, the firm expanded its U.S. presence by acquiring nutritional products business Seltzer Companies (1"The Tan Sheet" Sept. 11, 2006, In Brief)
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients